Lan Coffman

4.5k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

Lan Coffman is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Lan Coffman has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Reproductive Medicine. Recurrent topics in Lan Coffman's work include Cancer Cells and Metastasis (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Lan Coffman is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Lan Coffman collaborates with scholars based in United States, New Zealand and Spain. Lan Coffman's co-authors include Suzy V. Torti, Frank M. Torti, Mary Ann Knovich, Ronald J. Buckanovich, Wei Wang, Ralph B. D’Agostino, Huda I. Atiya, Leonard Frisbie, Chelsea Chandler and Derek Parsonage and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Lan Coffman

43 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum ferritin: Past, present and future

2010 639 citations Wei Wang, Mary Ann Knovich et al. Biochimica et Biophysica Acta (BBA) - General Subjects profile →
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

2021 230 citations Ayana T. Ruffin, Sayali Onkar et al. profile →

Peers

Countries citing papers authored by Lan Coffman

Since Specialization

Citations

This map shows the geographic impact of Lan Coffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Coffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Coffman more than expected).

Fields of papers citing papers by Lan Coffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Coffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Coffman. The network helps show where Lan Coffman may publish in the future.

Co-authorship network of co-authors of Lan Coffman

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Coffman. A scholar is included among the top collaborators of Lan Coffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Coffman. Lan Coffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjuvant therapy in early uterine serous carcinoma 2025 ·American Journal of Epidemiology ·(unknown), (unknown), T. Rinda Soong, (unknown), Sarah E. Taylor, Lan Coffman, Ronald J. Buckanovich, Haider Mahdi, Sushil Beriwal, Paniti Sukumvanich, Rohit Bhargava, Alexander Olawaiye	1
2	The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions 2024 ·Cancer Cell ·(unknown), (unknown), (unknown), Sheryl Kunning, (unknown), (unknown), Huda I. Atiya, Ayana T. Ruffin, Sarah A. Taylor, T. Rinda Soong, Riyue Bao, Lan Coffman, Tullia C. Bruno	24
3	Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer 2024 ·Cell Reports ·Leonard Frisbie, (unknown), Emma Dyer, (unknown), (unknown), Claudette M. St. Croix, Simon C. Watkins, (unknown), (unknown), (unknown), Huda I. Atiya, Nadine Hempel, Alexander T. Pearson, Lan Coffman	19
4	Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer 2024 ·Cancers ·(unknown), Michael W. Epperly, Renee Fisher, Wen‐Chi Hou, Donna Shields, Jan‐Peter van Pijkeren, Brian J. Leibowitz, Lan Coffman, Hong Wang, M. Saiful Huq, Ziyu Huang, Claude J. Rogers, Anda Vlad, Joel S. Greenberger, Amitava Mukherjee	4
5	Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation 2023 ·Cancers ·(unknown), Michael W. Epperly, Renee Fisher, Wen‐Chi Hou, Donna Shields, Jan‐Peter van Pijkeren, Amitava Mukherjee, Jian Yu, Brian J. Leibowitz, Anda Vlad, Lan Coffman, Hong Wang, M. Saiful Huq, Ziyu Huang, Claude J. Rogers, Joel S. Greenberger	7
6	Impact of Race and Socioeconomic Factors on Clinical Outcomes in Cervical and Endometrial Cancer Patients Treated with Brachytherapy 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Hui Wang, (unknown), (unknown), (unknown), (unknown), Lan Coffman, Ronald J. Buckanovich, Jamie Lesnock, (unknown), (unknown), (unknown), (unknown)	0
7	Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation 2022 ·Cancer Research ·Huda I. Atiya, Leonard Frisbie, (unknown), (unknown), Nicole Donnellan, Francesmary Modugno, Michael Calderon, Simon C. Watkins, Rugang Zhang, Esther Elishaev, T. Rinda Soong, Anda Vlad, Lan Coffman	30
8	Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer 2022 ·JCI Insight ·Lan Coffman, (unknown), (unknown), Leonard Frisbie, Daniel P. Normolle, Kent A. Griffith, Shitanshu Uppal, Karen McLean, Jessica Berger, M.M. Boisen, Madeleine Courtney‐Brooks, Robert P. Edwards, Jamie Lesnock, Haider Mahdi, Alexander Olawaiye, Paniti Sukumvanich, Sarah E. Taylor, Ronald J. Buckanovich	13
9	Call for action: expanding global access to hereditary cancer genetic testing 2022 ·The Lancet Oncology ·Brittany Bychkovsky, Huma Q. Rana, Foluso O. Ademuyiwa, Jennifer K. Plichta, Karen S. Anderson, Angélica Nogueira‐Rodrigues, Cesar A. Santa‐Maria, Lan Coffman, Carol Marquez, Arunangshu Das, A.G. Taghian, (unknown), Renata Lazari Sandoval, Ben Ho Park, Don S. Dizon	10
10	Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer 2022 ·Gynecologic Oncology Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ronald J. Buckanovich, Madeleine Courtney‐Brooks, Paniti Sukumvanich, Jessica Berger, Alexander Olawaiye, Haider Mahdi, M.M. Boisen, Robert P. Edwards, Lan Coffman, Sarah E. Taylor, Jamie Lesnock	4
11	Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition 2021 ·Science Advances ·Sandra Cascio, Chelsea Chandler, (unknown), (unknown), Bingsi Gao, Sayali Onkar, Tullia C. Bruno, Dario A.A. Vignali, Haider Mahdi, Hatice U. Osmanbeyoglu, Anda Vlad, Lan Coffman, Ronald J. Buckanovich	54
12	Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer 2021 ·Gynecologic Oncology ·(unknown), (unknown), Sushil Beriwal, Rohit Bhargava, J. Berger, Ronald J. Buckanovich, Lan Coffman, Madeleine Courtney‐Brooks, Abdulhussain E. Mahdi, Alexander Olawaiye, Paniti Sukumvanich, Sarah E. Taylor, Kenneth J. Smith, Jamie Lesnock	17
13	Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis 2020 ·Cell Reports ·Huihui Fan, Huda I. Atiya, Yeh Wang, Thomas R. Pisanic, Tza‐Huei Wang, Ie‐Ming Shih, Kelly K. Foy, Leonard Frisbie, Ronald J. Buckanovich, (unknown), Rochelle L. Tiedemann, Scott B. Rothbart, Chelsea Chandler, Hui Shen, Lan Coffman	44
14	Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth 2018 ·Oncogene ·Karen McLean, Lijun Tan, (unknown), Lan Coffman, Luke F. Peterson, Moshe Talpaz, Nouri Neamati, Ronald J. Buckanovich	64
15	New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination 2016 ·Translational research ·Lan Coffman, Daniela Burgos-Ojeda, Rong Wu, Kathleen R. Cho, Shoumei Bai, Ronald J. Buckanovich	68
16	Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells 2013 ·Cancer Biology & Therapy ·Lan Coffman, (unknown), Jae‐Young Lim, Shoumei Bai, Inês Pires da Silva, Yusong Gong, Kun Yang, Ronald J. Buckanovich	42
17	An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer 2011 ·Cancer Research ·Lance D. Miller, Lan Coffman, Jeff W. Chou, Michael A. Black, Jonas Bergh, Ralph B. D’Agostino, Suzy V. Torti, Frank M. Torti	169
18	Serum ferritin: Past, present and future breakdown → 2010 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Wei Wang, Mary Ann Knovich, Lan Coffman, Frank M. Torti, Suzy V. Torti	639
19	Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin 2008 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Lan Coffman, Julie C. Brown, David A. Johnson, Narayanan Parthasarathy, Ralph B. D’Agostino, Mark O. Lively, Xiaoyang Hua, Stephen L. Tilley, Werner Müller‐Esterl, Mark C. Willingham, Frank M. Torti, Suzy V. Torti	44
20	Ferritin for the clinician 2008 ·Blood Reviews ·Mary Ann Knovich, (unknown), Lan Coffman, Suzy V. Torti, Frank M. Torti	455

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact